Insider trading

Period: 120 months Stock: ARDX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

346 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

346 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

346 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

346 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
346 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
346 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

346 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
11 Jun 2020
SANDELL SCOTT D 10% owner · indirect
Sold, plan not stated
$284.46K 44,991 at 6.32
50.0%
11 Jun 2020
BASKETT FOREST 10% owner · indirect
Sold, plan not stated
$284.46K 44,991 at 6.32
50.0%
11 Jun 2020
BASKETT FOREST 10% owner · indirect
Sold, plan not stated
$138.99K 21,821 at 6.37
100%
Sold half or more
11 Jun 2020
BASKETT FOREST 10% owner · indirect
Sold, plan not stated
$6.88K 1,079 at 6.38
100%
Sold half or more
1 Jun 2020
RAAB MICHAEL President & CEO · indirect
Sold, plan not stated
$169.63K 23,128 at 7.33
33.3%
5 May 2020
RAAB MICHAEL President & CEO · indirect
Sold, plan not stated
$31.54K 4,486 at 7.03
6.1%
4 May 2020
RAAB MICHAEL President & CEO · indirect
Sold, plan not stated
$111.69K 15,941 at 7.01
17.7%
27 Apr 2020
GRAMMER ELIZABETH A See Remarks
Sold, plan not stated 4×
$133.17K 17,824 at 7.47
14.9%
17 Apr 2020
RAAB MICHAEL President & CEO · indirect
Sold, plan not stated
$66.17K 9,428 at 7.02
9.5%
16 Apr 2020
RAAB MICHAEL President & CEO · indirect
Sold, plan not stated
$73.64K 10,500 at 7.01
9.6%
15 Apr 2020
RAAB MICHAEL President & CEO · indirect
Sold, plan not stated
$3.52K 500 at 7.03
0.5%
2 Mar 2020
RAAB MICHAEL President & CEO · indirect
Sold, plan not stated
$143.28K 20,428 at 7.01
15.6%
2 Mar 2020
RAAB MICHAEL President & CEO
Sold, plan not stated
$77.86K 11,123 at 7.00
5.1%
5 Feb 2020
RAAB MICHAEL President & CEO
Sold, plan not stated
$182.93K 25,000 at 7.32
10.8%
30 Dec 2019
GRAMMER ELIZABETH A EVP, General Counsel · indirect
Bought
$495.92 66 at 7.51
3.3%
First buy on file
3 Dec 2019
GRAMMER ELIZABETH A EVP, General Counsel
Sold, plan not stated
$40.00K 5,000 at 8.00
4.1%
19 Nov 2019
GRAMMER ELIZABETH A EVP, General Counsel
Sold, plan not stated
$35.00K 5,000 at 7.00
4.1%
7 Oct 2019
Kaufmann Mark Chief Financial Officer
Sold, plan not stated
$91.19K 20,000 at 4.56
12.4%
22 Aug 2019
GRAMMER ELIZABETH A EVP, General Counsel
Sold, plan not stated
$3.32K 948 at 3.50
0.8%
21 Aug 2019
GRAMMER ELIZABETH A EVP, General Counsel
Sold, plan not stated
$14.18K 4,052 at 3.50
3.4%
19 Aug 2019
GRAMMER ELIZABETH A EVP, General Counsel
Sold, plan not stated
$0.00 5,874 at 0.00
4.6%
4 Jun 2019
RAAB MICHAEL President & CEO
Sold, plan not stated
$25.55K 10,054 at 2.54
3.8%
4 Jun 2019
Kaufmann Mark Chief Financial Officer
Sold, plan not stated
$8.55K 3,357 at 2.55
2.4%
4 Jun 2019
Rosenbaum David P. Chief Development Officer
Sold, plan not stated
$7.26K 2,856 at 2.54
1.8%
4 Jun 2019
GRAMMER ELIZABETH A SVP, General Counsel
Sold, plan not stated
$6.40K 2,520 at 2.54
1.9%
2 Jan 2019
RAAB MICHAEL President & CEO
Sold, plan not stated
$33.42K 19,644 at 1.70
7.0%
2 Jan 2019
Kaufmann Mark Chief Financial Officer
Sold, plan not stated
$11.15K 6,556 at 1.70
4.5%
2 Jan 2019
Rosenbaum David P. Chief Development Officer
Sold, plan not stated
$9.50K 5,585 at 1.70
3.4%
2 Jan 2019
GRAMMER ELIZABETH A EVP, General Counsel
Sold, plan not stated
$8.37K 4,920 at 1.70
3.7%
2 Jan 2019
Rosenbaum David P. Chief Development Officer · indirect
Sold, plan not stated
$1.36K 801 at 1.70
4.3%
13 Nov 2018
GRAMMER ELIZABETH A EVP, General Counsel
Sold, plan not stated
$18.57K 6,539 at 2.84
4.6%
13 Nov 2018
RAAB MICHAEL President & CEO
Sold, plan not stated
$18.57K 6,539 at 2.84
2.2%
13 Nov 2018
Kaufmann Mark Chief Financial Officer
Sold, plan not stated
$18.57K 6,539 at 2.84
4.3%
13 Nov 2018
Rosenbaum David P. Chief Development Officer
Sold, plan not stated
$15.82K 5,570 at 2.84
3.3%
12 Nov 2018
SANDELL SCOTT D 10% owner · indirect
Sold, plan not stated
$1.77K 592 at 2.98
100%
Sold half or more
30 May 2018
RINGOLD GORDON Director · indirect
Bought
$40.00K 10,000 at 4.00
66.7%
First buy on file
24 Oct 2017
Seeto Reginald Chief Operating Officer
Sold, plan not stated
$52.04K 10,008 at 5.20
6.3%
30 Aug 2017
BASKETT FOREST 10% owner · indirect
Sold, plan not stated
$2.40K 485 at 4.95
100%
Sold half or more
18 Apr 2017
Rosenbaum David P. Chief Development Officer
Sold, plan not stated
$24.58K 2,051 at 11.98
4.9%
10 Mar 2017
Rosenbaum David P. SVP, Drug Development · indirect
Sold, plan not stated
$13.48K 1,000 at 13.48
43.9%
3 Mar 2017
Caldwell Jeremy S EVP, Chief Scientific Officer
Sold, plan not stated
$14.51K 1,026 at 14.14
5.4%
1 Mar 2017
Jacobs Jeffrey W SVP, Technical Operations
Sold, plan not stated
$41.10K 3,000 at 13.70
4.2%
1 Feb 2017
Jacobs Jeffrey W SVP, Technical Operations
Sold, plan not stated
$36.00K 3,000 at 12.00
4.3%
5 Jan 2017
Korner Paul EVP, Chief Medical Officer
Sold, plan not stated
$79.38K 6,130 at 12.95
10.1%
16 Dec 2016
Rosenbaum David P. SVP, Drug Development · indirect
Sold, plan not stated
$13.04K 900 at 14.48
58.6%
Sold half or more
11 Nov 2016
Caldwell Jeremy S EVP, Chief Scientific Officer
Sold, plan not stated
$32.65K 2,158 at 15.13
100%
Sold half or more
Showing 301–346 of 346. ← Newer Page 7 of 7